Integral Diagnostics merger update

Integral Diagnostics Limited (ASX: IDX) has announced progress in its proposed merger with Capitol Health Limited (ASX: CAJ). The Australian Competition and Consumer Commission (ACCC) will not oppose the merger following IDX's agreement to divest Capitol's clinic in Melton, Victoria. Capitol Health will now seek the Federal Court of Australia's approval, aiming for a merger implementation on 20 December 2024, subject to court orders.

Merger update and outlook

Integral Diagnostics Limited (ASX: IDX) is advancing its merger with Capitol Health Limited, with the ACCC's approval contingent on divesting Capitol's Melton clinic. The next step is obtaining the Federal Court's approval, with an expected merger completion date of 20 December 2024, pending court orders. Integral Diagnostics is a leading provider of medical imaging services across Australia and New Zealand, and this merger is poised to strengthen its market position. Despite the positive developments, the company cautions that forward-looking statements are based on current assumptions and are subject to risks and uncertainties.

Executive commentary on merger

The ACCC's clearance is a significant step forward in our proposed merger with Capitol Health. We remain committed to completing the process and look forward to the opportunities this merger will bring.